SCHEMBL18280372

SCHEMBL18280372

Cc1ccc(C(=O)O)c(C)c1CBr

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAAO P46952 1/20 0.39
CYP1A2 P05177 2/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NOTUM Q6P988 1/20 0.36
MCL1 Q07820 1/20 0.36
TSHR P16473 1/20 0.36
RXRA P19793 2/20 0.36
RXRB P28702 2/20 0.36
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2258690 0.86 HAAO (0.40) HAAOCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL8921714 0.83 CYP1A2 (0.37) HAAOCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL8384754 0.83 HAAO (0.38) HAAOCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL7409160 0.82 GABRP (0.41) HAAOCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL13199183 0.82 PTGER4 (0.41) HAAOCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL1963804 0.81 TSHR (0.40) HAAOCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL9294588 0.81 HAAO (0.39) HAAOCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL23703865 0.81 HAAO (0.39) HAAOCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL8226800 0.79 GABRP (0.41) HAAOCYP1A2ALDH1A1KDM4EHPGD
SCHEMBL28122101 0.79 HAAO (0.38) HAAOCYP1A2ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303415-B1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF ALCON INC (CH) 2022-12-28 EP disclosed
US-10324311-B2 Visible-light photoinitiators and uses thereof NOVARTIS AG (CH) 2019-06-18 US disclosed
EP-3303415-A1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF Novartis AG (CH) 2018-04-11 EP disclosed
US-20160357031-A1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF ALCON INC. (CH) 2016-12-08 US disclosed
WO-2016193912-A1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF NOVARTIS AG (CH) 2016-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10324311-B2 Visible-light photoinitiators and uses thereof SIRT5, IK, IGLV6-57 HAAO 2014/4885CYP1A2 1874/4885ALDH1A1 1953/4885
US-20160357031-A1 VISIBLE-LIGHT PHOTOINITIATORS AND USES THEREOF SIRT5, IK, IGLV6-57 HAAO 2014/4885CYP1A2 1874/4885ALDH1A1 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.